Evidence Rating Level: 2 (Good) Study Rundown: Obesity increases the risk for knee osteoarthritis, and people with obesity tend to present with more severe pain and functional limitations than those without obesity
GIP receptors in skeletal muscle may also reduce protein breakdown during caloric restriction, part of why tirzepatide shows slightly better muscle preservation than semaglutide at matched weight loss
youve got a crew behind you every step of the way
[21] [22] Emerging evidence, primarily from observational and retrospective studies, suggests that GLP-1 receptor agonists may produce additional weight loss in post-bariatric patients
Some people tolerate one better than the other for reasons that vary individually
While Wegovy is indicated for chronic weight management with or without diabetes, Ozempic is primarily approved for managing type 2 diabetes 1 , 2